Tharimmune, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell THAR and other ETFs, options, and stocks.About THAR
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or "uncontrollable itching" in PBC, a rare and orphan liver disease with no known cure.
THAR Key Statistics
Stock Snapshot
With a market cap of 176.9M, Tharimmune, Inc.(THAR) trades at $4.44. The stock has a price-to-earnings ratio of -1.15.
On 2026-02-13, Tharimmune, Inc.(THAR) stock moved within a range of $4.21 to $4.65. With shares now at $4.44, the stock is trading +5.5% above its intraday low and -4.4% below the session's peak.
Trading volume for Tharimmune, Inc.(THAR) stock has reached 469.56K, versus its average volume of 1.38M.
The stock's 52-week range extends from a low of $0.95 to a high of $9.08.
The stock's 52-week range extends from a low of $0.95 to a high of $9.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.